Login or Join
 Learn then Earn
stockMarketNEWS

 story : CinCor Pharma sets IPO terms, as the biotech looks to raise up to 7 million #FinanceUSA #StockMarketNEWS CinCor Pharma Inc. has set terms for its initial public offering, in which the Massachusetts-based

@stockMarketNEWS 14 Days ago

Posted in: #FinanceUSA #StockMarketNEWS

CinCor Pharma sets IPO terms, as the biotech looks to raise up to 7 million #FinanceUSA #StockMarketNEWS
CinCor Pharma Inc. has set terms for its initial public offering, in which the Massachusetts-based biopharmaceutical company focusing on treatments of hypertension, could be valued at up to 2.1 million. The company could raise up to 7.0 million, as it is offering 11.0 million shares in the IPO, which is expected to price between and a share. The stock is expected to list on the Nasdaq under the ticker symbol "CINC." Morgan Stanley, Jefferies and Evercore ISI are the lead underwriters. The company has recorded a net loss of .0 million on no revenue during the nine months ended Sept. 30, after a loss of .5 million on no revenue in the same period a year ago. The company is looking to go public at a time that the Renaissance IPO ETF has dropped 9.8% over the past three months, while the iShares Biotechnology ETF has lost 4.0% and the S&P 500 has gained 9.4%.


Munafa USA Munafa India Munafa NSE


Report

Login to follow story

More posts by @stockMarketNEWS

Munafa ebook, learn stock market trading

0 Comments

Sorted by latest first Latest Oldest Best

Daily analysis, news, Munafa stocks list in email:

Back to top | Use Dark Theme